INS and fibrosis: Contrary to expectations, this study did not find a significant correlation between HCV therapy with DAAs and DM development in patients with cirrhosis, while in non-diabetic lean patients, therapy of HCV enhances peripheral (but not hepatic) insulin sensitivity in CHC without significant fibrosis (45).